Home | Contact
  • Company
    • Company Profile
    • Clinical Need
    • Board of Directors
    • Management Team
    • Compliance
    • Careers
    • Media
  • Products
  • PATIENTS
  • PHYSICIANS
  • CONTACT

company press

The Interventional Management of Stroke (IMS) III Trial Protocol Now Includes The Penumbra System, An Aspiration-Based Thrombectomy Device For Interventional Debulking And Removal Of Cerebral Clots In Acute Stroke Patients. October 21, 2009, 11:28 AM PDT

Penumbra, Inc. Enrolls First Patient In The START Clinical Trial To Define Image Guided Patient Selection Criteria For Interventional Acute Ischemic Stroke Treatment. October 7, 2009, 12:23 PM PDT

Penumbra Announces Worldwide Voluntary Field Removal of the Original Version of 6F Neuron 070 Delivery Catheter. September 29, 2009, 5:00 pm PDT

First Multi-Center Real World Clinical Data On Use of The Penumbra System In Acute Ischemic Stroke Is Presented At The International Stroke Conference’s “Best Science of the ISC” Session. February 20, 2009, 12:30 PST

Clinical Data From The Pivotal Penumbra Stroke Trial Presented At The International Stroke Conference’s Late Breaking Science Session. February 22, 2008, 12:21 pm CST

Penumbra, Inc. Announces 510(k) Clearance Of The Penumbra System™ For Use In The Revascularization Of Patients With Acute Ischemic Stroke.

January 7, 2008, 4:00 am PDT

Penumbra, Inc. Completes Pivotal Stroke Trial of Intracranial Revascularization
September 5, 2007, 5:00 am PDT

Home Careers Press Products Clinical Data Contact Us

User Agreement|Privacy Policy
Copyright © 2009 Penumbra, Inc., 1351 Harbor Bay Pkwy, Alameda, CA 94502. All rights reserved.